Gut Oxygenation and Laparoscopy

Sponsor
University of Milano Bicocca (Other)
Overall Status
Completed
CT.gov ID
NCT01040013
Collaborator
(none)
40
1
2
18
2.2

Study Details

Study Description

Brief Summary

Patients with left-colon cancer will be randomized to laparoscopic or laparotomic operation. during surgery and for 6 days after operation, intestinal oxygen tension and ischemia-reperfusion injury markers will be evaluated to understand if pneumoperitoneum is associated with reduced splanchnic blood flow and ischemia-reperfusion injury.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopy
  • Procedure: left colectomy by laparotomy
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
GUT OXYGENATION DURING AND AFTER LAPAROSCOPIC AND OPEN COLON RESECTION. A RANDOMIZAD CLINICAL TRIAL
Study Start Date :
Mar 1, 2008
Actual Primary Completion Date :
Mar 1, 2009
Actual Study Completion Date :
Sep 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Laparoscopy

Laparoscopic Left-Sided Colectomy

Procedure: Laparoscopy
Laparoscopic Left-Colectomy

Active Comparator: laparotomy

Laparotomic Left-Sided Colectomy

Procedure: left colectomy by laparotomy
PatientS will be operated by laparotomy

Outcome Measures

Primary Outcome Measures

  1. Intestinal oxygenation [7 DAYS]

Secondary Outcome Measures

  1. Ischemic reperfusion injury [7 DAYS]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Proven Cleft Colon Cancer, Signed Informed Consent
Exclusion Criteria:
  • Emergency surgery,

  • Cancer infiltrating adjacent organ (at CT scan),

  • Severe cardiovascular (New York Heart Association class > 3 ),

  • Respiratory (arterial PO2 < 70 mmHg),

  • Renal (plasma creatinine > 3 MG/dL) or hepatic (Child C) dysfunction

Contacts and Locations

Locations

Site City State Country Postal Code
1 San Gerardo Hospital Monza Italy 20052

Sponsors and Collaborators

  • University of Milano Bicocca

Investigators

  • Principal Investigator: Luca Gianotti, MD, PhD, Milano-Bicocca university

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01040013
Other Study ID Numbers:
  • oxylap-2009
First Posted:
Dec 25, 2009
Last Update Posted:
Dec 25, 2009
Last Verified:
Nov 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 25, 2009